Prion Protein-Hemin Interaction Upregulates Hemoglobin Synthesis: Implications for Cerebral Hemorrhage and Sporadic Creutzfeldt-Jakob Disease
Overview
Neurology
Authors
Affiliations
Hemin is known to induce endocytosis of prion-protein (PrP(C)) from the neuronal plasma membrane, potentially limiting propagation of the disease causing PrP-scrapie (PrP(Sc)) isoform. Hemin is therefore an attractive disease-modifying option for sporadic Creutzfeldt-Jakob disease (sCJD), a human prion disorder with no effective treatment. The hemin-PrP(C) interaction is also of interest in cerebral-hemorrhage (CH), a condition where potentially toxic hemin molecules come in contact with neuronal PrP(C). Interestingly, PrP(C) is upregulated in penumbric neurons surrounding CH and is known to confer neuroprotection in a dose-dependent manner. The underlying mechanism, however, is not clear. Here, we report that hemin binds PrP(C) on diverse cell lines, resulting in its aggregation or degradation in a cell-type specific manner. Surprisingly, the hemin-PrP(C) interaction upregulates Hb synthesis in hematopoietic cells, a response reversed by deleting the hemin-binding octa-peptide repeat region of PrP(C). A similar response is noted in brain organotypic cultures where exposure to hemin induces significantly more α-globin in wild-type (PrP(+/+)) relative to PrP-knock-out (PrP(-/-)) samples. Furthermore, red blood cells and brain tissue from PrP(-/-) mice show significantly less α-globin relative to PrP(+/+) controls, indicating a positive effect of PrP(C) on Hb synthesis under physiological conditions as well. Surprisingly, levels of α-globin are significantly higher in sCJD brain tissue relative to controls, suggesting compensatory upregulation of Hb synthesis by surviving neurons or misregulation in diseased brains. These observations reveal a unique function of PrP(C) that is likely to impact the therapeutic management of CH and sCJD.
Erythrocyte Indices in Creutzfeldt-Jakob Disease Predict Survival Time.
Kong Y, Chen Z, Zhang J, Wu L Front Neurol. 2022; 13:839081.
PMID: 35237232 PMC: 8884143. DOI: 10.3389/fneur.2022.839081.
Melatonin: Regulation of Prion Protein Phase Separation in Cancer Multidrug Resistance.
Loh D, Reiter R Molecules. 2022; 27(3).
PMID: 35163973 PMC: 8839844. DOI: 10.3390/molecules27030705.
Interaction between Hemin and Prion Peptides: Binding, Oxidative Reactivity and Aggregation.
DellAcqua S, Massardi E, Monzani E, Di Natale G, Rizzarelli E, Casella L Int J Mol Sci. 2020; 21(20).
PMID: 33066163 PMC: 7589926. DOI: 10.3390/ijms21207553.
Dharmalingam P, Talakatta G, Mitra J, Wang H, Derry P, Nilewski L ACS Nano. 2020; 14(3):2827-2846.
PMID: 32049495 PMC: 7850811. DOI: 10.1021/acsnano.9b05821.
Ouyang Y, Li D, Wang H, Wan Z, Luo Q, Zhong Y Aging Cell. 2019; 18(6):e13022.
PMID: 31400088 PMC: 6826124. DOI: 10.1111/acel.13022.